-transparent.png){kind=logo}
21 patients with metastatic breast cancer, refractory to conventional agents, were treated with a combination of BCNU, vincristine, mitomycin-C and prednisone given every 4 weeks. Only three of the nineteen (15.8%) evaluable patients were observed to have a partial remission, whereas four experienced stabilization of tumor. The sites which responded included skin lesions in two patients and a pleural effusion in 1 patient. This combination resulted in moderate to severe thrombocytopenia in five patients, but was otherwise well tolerated. This pilot study therefore suggests that these four agents in the schedule and doses given do not appear to be superior to any of these agents used singly for advanced, refractory breast cancer.
N J DiBella, and
D Garfield, and
K Fink, and
P Anderson, and
J Speer, and
J Murphy
March 1982,
Cancer treatment reports,
N J DiBella, and
D Garfield, and
K Fink, and
P Anderson, and
J Speer, and
J Murphy
March 1983,
Gan to kagaku ryoho. Cancer & chemotherapy,
N J DiBella, and
D Garfield, and
K Fink, and
P Anderson, and
J Speer, and
J Murphy
October 1984,
Cancer,
N J DiBella, and
D Garfield, and
K Fink, and
P Anderson, and
J Speer, and
J Murphy
February 1974,
Cancer,
N J DiBella, and
D Garfield, and
K Fink, and
P Anderson, and
J Speer, and
J Murphy
January 1987,
The Korean journal of internal medicine,
N J DiBella, and
D Garfield, and
K Fink, and
P Anderson, and
J Speer, and
J Murphy
January 1985,
Oncology,
N J DiBella, and
D Garfield, and
K Fink, and
P Anderson, and
J Speer, and
J Murphy
May 1984,
Cancer,
N J DiBella, and
D Garfield, and
K Fink, and
P Anderson, and
J Speer, and
J Murphy
November 1982,
Cancer treatment reports,
N J DiBella, and
D Garfield, and
K Fink, and
P Anderson, and
J Speer, and
J Murphy
January 1991,
Journal of cancer research and clinical oncology,
N J DiBella, and
D Garfield, and
K Fink, and
P Anderson, and
J Speer, and
J Murphy
January 1979,
Cancer treatment reports,
